Return to Course LibraryCE InformationBibliography

Release Date:

Expiration Date:




Bruce A. Porter, MD, FACR
Medical Director
Swedish/First Hill Diagnostic Imaging

Clinical Associate Professor
University of Washington




Equipment Requirements

PC: Windows XP/Vista/Win7, Pentium processor or faster, at least 1 GB RAM, Internet Explorer version 8 and 9, Mozilla FireFox version 15.

MAC: OS version 10.6/10.7/10/8, Intel processor or faster, at least 1 GB RAM, Safari version 5, FireFox version 15.



Breast MRI Case Review: A focus on preoperative planning


Recording of a live webinar presented on June 28, 2011

A certified one-hour program for medical imaging and healthcare professionals including: radiologists, interventional radiologists, oncologists and surgeons with a focus on preoperative planning.

Format: Archived Webinar
MD Credit:  1.0 AMA PRA Category 1
(Available for physician credit only)
RT Credit:   No ARRT credit available
Fee for Credit Certificate: $0

Click the ENROLL NOW icon to the left to view this program ONLINE.


Course Overview
In the United States, breast cancer is the most common non-skin cancer and the second leading cause of cancer-related death in women.1 Early detection and treatment can often mean the difference between life and death.

Based on recent evidence on the efficacy of breast magnetic resonance imaging (MRI) screening in high-risk patients, the American Cancer Society (ACS) has issued guidelines for the early detection of breast cancer that include MRI.2 Additionally, MRI is emerging as an important tool in the treatment of breast cancer patients to evaluate the extent of disease, assess tumor response to neoadjuvant chemotherapy, and for preoperative planning.

This series brings to learners the opportunity to view a variety of breast MRI cases as expert faculty share their experience and approach to breast MRI in their practice.

1  Source for incidence and mortality data: Surveillance, Epidemiology, and End Results (SEER) Program and the National Center for Health Statistics.  Available at
2  Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89.

Educational Objectives for the Series
At the conclusion of this activity, participants should be more confident to:

  • Develop a systematic strategy to interpret breast MR images and improve diagnostic accuracy
  • Use standardized terminology to assess and report breast MRI abnormalities in accordance with ACR BI-RADS® for MRI
  • Evaluate the role of morphology and kinetics when assessing a breast lesion
  • Apply standard methods and strategies for MRI-guided breast biopsy intervention

Accreditation & Credit
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and the International Center for Postgraduate Medical Education (ICPME). PIM is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

How to Participate
You will need a computer with Internet access. There are no fees or prerequisite for this program.

  • Click the blue link. Complete the precourse evaluation and click SUBMIT.
  • Once the precourse evaluation is submitted, click on the blue link again to view the course.
  • Click on PLAYBACK. To view the streaming video, you may have to download the WebEx Player or Java.

    Please note: The WebEx platform will play on desktop or laptop computers only. It will not play on mobile devices.

How to Receive Credit

  • Log-in to your account at
  • View the entire one-hour session. The question-and-answer period at the end of the lecture is not required to receive credit.
  • At the conclusion of the lecture, close the WebEx Player window. You will be redirected to the ICPME website.
  • From the COURSE HOME page, click the button for EVALUATION.
  • After completing the EVALUATION, click the certificate tab to print a credit certificate.

Faculty Biography
Dr. Porter is a co-founder and medical director of First Hill Diagnostic Imaging in Seattle, WA. Established in 1984, FHDI was the first facility in the Pacific Northwest to provide MRI services. In 2007, First Hill Diagnostic Imaging partnered with Swedish Medical Center to form the joint venture Swedish/First Hill Diagnostic Imaging.

In 1972, Dr. Porter received a B.S. in Medicine from University of North Dakota, School of Medicine. He then went on to complete his medical degree at University of California-Davis. Dr. Porter’s residency training includes Nuclear Medicine at Stanford University and Diagnostic Radiology at UC Davis. In 1981, Dr. Porter also completed a Fellowship in abdominal imaging, angiography, and interventional radiology at the University of Lund, Sweden.

Dr. Porter is a clinical associate professor at the University of Washington, an affiliate investigator at the Fred Hutchinson Cancer Research Center, on the staff of Swedish Hospital, and a fellow of the American College of Radiology.

Focusing especially on advanced MR and ultrasound of breast cancer, Dr. Porter has published numerous scientific papers. He is the author of multiple book chapters and scientific exhibits and has presented more than 300 lectures at national and international scientific meetings.

Disclosure of Conflicts of Interest

The Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationship or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Bruce A. Porter, MD, FACR, has received consulting fees from Merge Healthcare, Bard/SenoRx, Siemens Medical Solutions, Invivo, Hologic, Inc., Suros, and Sentinelle Medical    

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Sharon Cancino               
Jan Hixon, RN, BSN, MA       
Trace Hutchison, PharmD       
Julia Kimball, RN, BSN           
Samantha Mattiucci, PharmD       
Victoria Phoenix, BS
Lisa Schleelein, MEd
Patricia Staples, MSN, NP-C, CCRN

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. PIM, ICPME and Hologic, Inc., do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ICPME and Hologic, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

For questions regarding this program, please contact ICPME:
Phone: 607-257-5860

Jointly Sponsored by


This activity is supported by an educational grant from